Gyre Therapeutics, Inc.

General ticker "GYRE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $654.8M (TTM average)

Gyre Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -11.3%.

Estimated limits based on current volatility of 2.6%: low 4.35$, high 4.65$

Factors to consider:

  • Total employees count: 618 (+7.7%) as of 2025
  • Top business risk factors: Acquisition/divestiture risks, Product sales dependence, Market acceptance, Clinical trial failure, Capital shortage
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [3.12$, 8.12$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.06$, 7.77$]

Financial Metrics affecting the GYRE estimates:

  • Positive: with PPE of 78.5 at the end of fiscal year the price was neutral
  • Negative: Operating cash flow per share per price, % of 0.16 <= 1.94
  • Positive: 7.45 < Operating profit margin, % of 9.85
  • Positive: Inventory ratio change, % of 2.42 <= 4.15
  • Negative: -0.26 < Industry inventory ratio change (median), % of 0
  • Negative: Investing cash flow per share per price, % of -0.07 <= -0.07
  • Negative: 58.04 < Shareholder equity ratio, % of 63.82 <= 68.95
  • Positive: Interest expense per share per price, % of 0 <= 0

Similar symbols

Short-term GYRE quotes

Long-term GYRE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $110.11MM $105.69MM $116.58MM
Operating Expenses $177.34MM $89.53MM $105.10MM
Operating Income $-67.23MM $16.16MM $11.49MM
Non-Operating Income $-9.73MM $7.05MM $2.95MM
R&D Expense $96.88MM $12.02MM $13.70MM
Income(Loss) $-76.97MM $23.22MM $14.44MM
Taxes $8.52MM $5.32MM $4.56MM
Net Income(Loss)* $-92.93MM $12.09MM $5.03MM
Stockholders Equity $-15.83MM $63.32MM $106.03MM
Inventory $4.28MM $6.34MM $10.17MM
Assets $116.54MM $125.41MM $166.13MM
Operating Cash Flow $25.89MM $-3.64MM $1.01MM
Capital expenditure $8.59MM $3.13MM $1.19MM
Investing Cash Flow $-19.76MM $-19.88MM $-0.47MM
Financing Cash Flow $2.50MM $2.10MM $24.38MM
Earnings Per Share** $-1.41 $0.14 $0.06

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.